International: Page 2

Rubicon Organics Obtains Key Certification for International Export

The company’s dried cannabis products are now compliant with the World Health Organization’s guidelines on GACP medicinal plants.

Tilray Expands Medical Cannabis Portfolio in Germany

The company launched new cannabis extract products and formulations.

Tilray Brands Enhances Global Cannabis Supply Chain

The company increased its industry-leading capacity to meet global demand, driving growth across Canada and Europe.

Village Farms International Commences Sales at Leli Holland Subsidiary in Netherlands

The company meets previous guidance on the commencement of sales with deliveries of the first flower harvest to coffee shops.

High Tide to Enter German Medical Cannabis Market Through Acquisition of Purecan GmbH

The acquisition will give High Tide a majority stake in Purecan’s profitable operations.

Empowering the Next Generation: Aurora Cannabis Announces German Internship Program

The cannabis company launched the program at its manufacturing facility in Leuna, Germany, to cultivate future leaders in the medical cannabis industry.

Flora Growth Appoints Sammy Dorf, Verano Co-Founder, as Executive Chairman

Adds Verano Co-Founder to its Board as it Accelerates its Entry into the THC-Infused Beverage Market

Flora Growth Enters Supply Agreement With Curaleaf Targeting $450 Million German Cannabis Market

The agreement will facilitate the importation of high-quality medical cannabis products into Germany

Curaleaf Denies Having Supply Agreement With Flora Growth for German Market

Florida-based Flora Growth issued a press release indicating it partnered with Curaleaf to bring medical cannabis products to the European market.

Puro Announces Strategic Investment from Te Rūnanga o Kaikōura

The partnership will create employment opportunities and enhance community well-being.

Curaleaf Issues Report on Illicit Online Cannabis Sales, Urges UK Government Action

The international cannabis company’s report reveals serious health risks of mold, lead and synthetic cannabinoids in unregulated cannabis.

MedCana Subsidiary in Colombia Enters Negotiations With Australian Firm for Pharma Cannabis Supply

The company is poised to enter into a supply agreement with $1.2 million to $2.4 million annually.

Previous Page

Page 2 of 63

Next Page